糖尿病足血清学诊断标志物的研究进展

doi:10.3969/j.issn.1006-5725.2024.16.005

Abstract

Abstract:

Diabetic foot （DF）， a primary chronic complication of diabetes mellitus， contributes to a major disability and mortality in diabetic patients. DF is diagnosed mainly depending not only on clinical manifestations， signs， and related inspection， but also on recently emerging diagnostic means： biological markers. Inflammatory biomarkers are preferably used for its superiority in DF early diagnosis. In recently years， thanks to advancements of biological technologies， biomarkers such as procalcitonin （PCT）， C?reactive protein （CRP）， interleukins （ILs）， and tumor necrosis factor?alpha （TNF?α） have been comprehensively used in DF diagnosis. Moreover， biomarkers of genomics， proteomics， metabolomics， and metagenomics have been employed as well. In this review， we aim to comprehensively review the role of serum biomarkers in DF diagnosis and risk stratification， elaborating on the current research status in applying serum biomarkers for DF prevention， diagnosis， and prognosis assessment.

Key words: diabetic foot, diagnostic marker, serological biomarkers

CLC Number:

R587.1

Kaming YANG,Zhenlin LI,Wanwen LAO,Aixia ZHAI,Changlong. BI. Serological biomarkers for diagnosis of diabetes foot： A review of literature[J]. The Journal of Practical Medicine, 2024, 40(16): 2224-2228.

References 37

1	Diabetes Atlas IDF. 2022 ［DB/OL］（.
2	GAZZARUSO C， GALLOTTI P， PUJIA A， et al. Predictors of healing， ulcer recurrence and persistence， amputation and mortality in type 2 diabetic patients with diabetic foot： a 10-year retrospective cohort study ［J］. Endocrine，2021，71（1）：59-68. doi:10.1007/s12020-020-02431-0 doi: 10.1007/s12020-020-02431-0
3	MONTEIRO-SOARES M， SCHAPER N C. Definitions and criteria for diabetic foot disease ［J］. Diabetes Metab Res Rev， 2020，36 （）：e3268. doi:10.1002/dmrr.3268 doi: 10.1002/dmrr.3268
4	DEN DEKKER A， DAVIS F M， KUNKEL S L， et al. Targeting epigenetic mechanisms in diabetic wound healing ［J］. Transl Res，2019，204：39-50. doi:10.1016/j.trsl.2018.10.001 doi: 10.1016/j.trsl.2018.10.001
5	LI B， LUAN S， CHEN J， et al. The MSC-Derived Exosomal lncRNA H19 Promotes Wound Healing in Diabetic Foot Ulcers by Upregulating PTEN via MicroRNA-152-3p ［J］. Mol Ther Nucleic Acids， 2020，19：814-826. doi:10.1016/j.omtn.2019.11.034 doi: 10.1016/j.omtn.2019.11.034
6	UMAPATHY D， DORNADULA S， RAJAGOPALAN A， et al. Potential of circulatory procalcitonin as a biomarker reflecting inflammation among South Indian diabetic foot ulcers ［J］. J Vasc Surg， 2018，67（4）：1283-1291.e2. doi:10.1016/j.jvs.2017.02.060 doi: 10.1016/j.jvs.2017.02.060
7	MELONI M， IZZO V， GIURATO L， et al. Procalcitonin Is a Prognostic Marker of Hospital Outcomes in Patients with Critical Limb Ischemia and Diabetic Foot Infection ［J］. J Diabetes Res， 2019，2019：4312737. doi:10.1155/2019/4312737 doi: 10.1155/2019/4312737
8	TODOROVA A S， DIMOVA R B， CHAKAROVA N Y， et al. Comparative Evaluation of the Diagnostic Value of Procalcitonin and hsCRP for the Presence of Mild-to-Moderate Diabetic Foot Infections ［J］. Int J Low Extrem Wounds， 2023，22（2）：353-359. doi:10.1177/15347346211011849 doi: 10.1177/15347346211011849
9	INGRAM J R， CAWLEY S， COULMAN E， et al. Levels of wound calprotectin and other inflammatory biomarkers aid in deciding which patients with a diabetic foot ulcer need antibiotic therapy （INDUCE study）［J］. Diabet Med， 2018，35（2）：255-261. doi:10.1111/dme.13431 doi: 10.1111/dme.13431
10	MCFADYEN J D， KIEFER J， BRAIG D， et al. Dissociation of C-Reactive Protein Localizes and Amplifies Inflammation： Evidence for a Direct Biological Role of C-Reactive Protein and Its Conformational Changes ［J］. Front Immunol， 2018，9：1351. doi:10.3389/fimmu.2018.01351 doi: 10.3389/fimmu.2018.01351
11	METINEREN H， DÜLGEROĞLU T C. Comparison of the Neutrophil/Lymphocyte Ratio and C-Reactive Protein Levels in Patients With Amputation for Diabetic Foot Ulcers ［J］. Int J Low Extrem Wounds， 2017，16（1）：23-28. doi:10.1177/1534734617696729 doi: 10.1177/1534734617696729
12	LAVERY L A， AHN J， RYAN E C， et al. Erratum to： What are the Optimal Cutoff Values for ESR and CRP to Diagnose Osteomyelitis in Patients with Diabetes-related Foot Infections？［J］. Clin Orthop Relat Res， 2020，478（4）：923. doi:10.1097/corr.0000000000001192 doi: 10.1097/corr.0000000000001192
13	ZUBAIR M， AHMAD J. Role of growth factors and cytokines in diabetic foot ulcer healing： A detailed review ［J］. Rev Endocr Metab Disord， 2019，20（2）：207-217. doi:10.1007/s11154-019-09492-1 doi: 10.1007/s11154-019-09492-1
14	CHEN Z， QIN X， ZHANG X， et al. Upregulation of IL-4 signaling contributes to aerobic exercise-induced insulin sensitivity ［J］. Biochem Biophys Res Commun， 2020，525（3）：662-667. doi:10.1016/j.bbrc.2020.02.103 doi: 10.1016/j.bbrc.2020.02.103
15	HAMMAD R， ELMADBOULY A A， AHMAD I H， et al. T-Natural Killers and Interferon Gamma/Interleukin 4 in Augmentation of Infection in Foot Ulcer in Type 2 Diabetes ［J］. Diabetes Metab Syndr Obes， 2021，14：1897-1908. doi:10.2147/dmso.s305511 doi: 10.2147/dmso.s305511
16	VISWANATHAN V， DHAMODHARAN U， SRINIVASAN V， et al. Single nucleotide polymorphisms in cytokine/chemokine genes are associated with severe infection， ulcer grade and amputation in diabetic foot ulcer ［J］. Int J Biol Macromol， 2018，118（Pt B）：1995-2000. doi:10.1016/j.ijbiomac.2018.07.083 doi: 10.1016/j.ijbiomac.2018.07.083
17	CRISOLOGO P A， DAVIS K E， AHN J， et al. The infected diabetic foot： Can serum biomarkers predict osteomyelitis after hospital discharge for diabetic foot infections？［J］. Wound Repair Regen， 2020，28（5）：617-622. doi:10.1111/wrr.12836 doi: 10.1111/wrr.12836
18	RAI V， MOELLMER R， AGRAWAL D K. The role of CXCL8 in chronic nonhealing diabetic foot ulcers and phenotypic changes in fibroblasts： a molecular perspective ［J］. Mol Biol Rep， 2022，49（2）：1565-1572. doi:10.1007/s11033-022-07144-3 doi: 10.1007/s11033-022-07144-3
19	ZHANG F， LIU Y， WANG S， et al. Interleukin-25-Mediated-IL-17RB Upregulation Promotes Cutaneous Wound Healing in Diabetic Mice by Improving Endothelial Cell Functions ［J］. Front Immunol， 2022，13：809755. doi:10.3389/fimmu.2022.809755 doi: 10.3389/fimmu.2022.809755
20	KOLUMAM G， WU X， LEE W P， et al. IL-22R Ligands IL-20， IL-22， and IL-24 Promote Wound Healing in Diabetic db/db Mice ［J］. PLoS One， 2017，12（1）：e0170639. doi:10.1371/journal.pone.0170639 doi: 10.1371/journal.pone.0170639
21	Angiogenesis in Health， Diseases and Malignancy ［J］. Anticancer Res， 2016， 36： 3226. doi:10.1007/978-3-319-28140-7_6 doi: 10.1007/978-3-319-28140-7_6
22	DHAMODHARAN U， TEENA R， VIMAL KUMAR R， et al. Circulatory levels of B-cell activating factor of the TNF family in patients with diabetic foot ulcer： Association with disease progression ［J］. Wound Repair Regen， 2019，27（5）：442-449. doi:10.1111/wrr.12720 doi: 10.1111/wrr.12720
23	OZER BALIN S， SAGMAK TARTAR A， UĞUR K， et al. Pentraxin-3： A new parameter in predicting the severity of diabetic foot infection？［J］. Int Wound J， 2019，16（3）：659-664. doi:10.1111/iwj.13075 doi: 10.1111/iwj.13075
24	TAKASHI Y， KOGA M， MATSUZAWA Y， et al. Circulating pentraxin 3 is positively associated with chronic hyperglycemia but negatively associated with plasma aldosterone concentration ［J］. PLoS One， 2018，13（5）：e0196526. doi:10.1371/journal.pone.0196526 doi: 10.1371/journal.pone.0196526
25	RASMUSSEN L J H， PETERSEN J E V， EUGEN-OLSEN J. Soluble Urokinase Plasminogen Activator Receptor （suPAR） as a Biomarker of Systemic Chronic Inflammation ［J］. Front Immunol，2021，12：780641. doi:10.3389/fimmu.2021.780641 doi: 10.3389/fimmu.2021.780641
26	ASLAN S， DEMIRDAL T， ERBAK H， et al. The role of soluble urokinase plasminogen activator receptor （suPAR） in the diagnostics of diabetic foot infection ［J］. Infect Dis （Lond）， 2020，52（2）：107-113. doi:10.1080/23744235.2019.1688387 doi: 10.1080/23744235.2019.1688387
27	ZUBAIR M， AHMAD J. Heat Shock Protein 70 Gene Single Nucleotide Polymorphism and Diabetic Foot Ulcer. Is There Any Relationship？［J］. J Clin Med， 2018，7（8）：187. doi:10.3390/jcm7080187 doi: 10.3390/jcm7080187
28	LI X， LU Y， WEI P. Association between VEGF genetic variants and diabetic foot ulcer in Chinese Han population： A case-control study ［J］. Medicine （Baltimore）， 2018， 97（20）：e10672. doi:10.1097/md.0000000000010672 doi: 10.1097/md.0000000000010672
29	PICHU S， SATHIYAMOORTHY J， VIMALRAJ S， et al. Impact of lysyl oxidase （G473A） polymorphism on diabetic foot ulcers ［J］. Int J Biol Macromol， 2017，103：242-247. doi:10.1016/j.ijbiomac.2017.05.050 doi: 10.1016/j.ijbiomac.2017.05.050
30	LIN C J， LAN YM， OU M Q， et al. Expression of miR-217 and HIF-1α/VEGF pathway in patients with diabetic foot ulcer and its effect on angiogenesis of diabetic foot ulcer rats ［J］. J Endocrinol Invest， 2019，42（11）：1307-1317. doi:10.1007/s40618-019-01053-2 doi: 10.1007/s40618-019-01053-2
31	AMIN K N， UMAPATHY D， ANANDHARAJ A， et al. miR-23c regulates wound healing by targeting stromal cell-derived factor-1α （SDF-1α/CXCL12） among patients with diabetic foot ulcer ［J］. Microvasc Res， 2020，127：103924. doi:10.1016/j.mvr.2019.103924 doi: 10.1016/j.mvr.2019.103924
32	GAO J， ZHAO G， LI W， et al. MiR-155 targets PTCH1 to mediate endothelial progenitor cell dysfunction caused by high glucose ［J］. Exp Cell Res， 2018，366（1）：55-62. doi:10.1016/j.yexcr.2018.03.012 doi: 10.1016/j.yexcr.2018.03.012
33	JONES J I， NGUYEN T T， PENG Z， et al. Targeting MMP-9 in Diabetic Foot Ulcers ［J］. Pharmaceuticals （Basel）， 2019，12（2）：79. doi:10.3390/ph12020079 doi: 10.3390/ph12020079
34	HUNG S Y， TSAI J S， YEH J T， et al. Amino acids and wound healing in people with limb-threatening diabetic foot ulcers ［J］. J Diabetes Complications， 2019，33（10）：107403. doi:10.1016/j.jdiacomp.2019.06.008 doi: 10.1016/j.jdiacomp.2019.06.008
35	SADEGHPOUR HERAVI F， ZAKRZEWSKI M， VICKERY K， et al. Bacterial Diversity of Diabetic Foot Ulcers： Current Status and Future Prospectives ［J］. J Clin Med， 2019，8（11）：1935. doi:10.3390/jcm8111935 doi: 10.3390/jcm8111935
36	COLLIER A， MCLAREN J， GODWIN J， et al. Is Clostridium difficile associated with the '4C' antibiotics？ A retrospective observational study in diabetic foot ulcer patients ［J］. Int J Clin Pract， 2014，68（5）：628-632. doi:10.1111/ijcp.12347 doi: 10.1111/ijcp.12347
37	李婉媚，杨旭斌，黄懿文，等. 血糖波动对糖尿病大鼠心脏自主神经功能的影响及其机制［J］. 实用医学杂志， 2021，37（16）：2065-2068+2074. doi:10.3969/j.issn.1006-5725.2021.16.006 doi: 10.3969/j.issn.1006-5725.2021.16.006

[1]	Junpeng LIU,Xinru DU,Xingchen YAO,Ziyu XU,Fuchun PEI,Lin ZHANG,Hui. ZHAO. Micro⁃osteotomy bone transport combined with vacuum sealing drainage for the treatment of diabetic foot： A retrospective cohort study of 128 patients from two centers [J]. The Journal of Practical Medicine, 2024, 40(18): 2590-2596.
[2]	LUO Fuqiang, YU Dianbai, XIE Kangqi, LI Zaiyong, ZHOU Haidong, LUO Changtai, WEI Jihua. . Research progress on the mechanism of diabetic foot ulcer wound repair [J]. The Journal of Practical Medicine, 2023, 39(2): 158-163.
[3]	CHEN Cunren, FANG Tuanyu, MO Zewei, WEI Weiping, CEN Chaoping, ZHANG Yan, LIN Lu, QUAN Huibiao. . Effect of vacuum sealing drainage combined with micro-dynamic vacuum pack dressings in accelerating healing of diabetic foot wounds [J]. The Journal of Practical Medicine, 2021, 37(9): 1164-1167.
[4]	WANG Cheng, CHEN Chaogang, YANG Chuan, LIANG Ping, HE Fengyi, LU Jiahui, YAN Li. . Analysis on the dietary nutrient intake of middle ⁃ aged and elderly patients with diabetic foot [J]. The Journal of Practical Medicine, 2021, 37(20): 2681-2686.

Serological biomarkers for diagnosis of diabetes foot： A review of literature

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References 37

Related Articles 4

Recommended Articles

Metrics

Comments